Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Orbia
United States
- Boston
- 28/11/2022
- Series B
- $10,000,000
Orbia is a company driven by a shared purpose: to advance life around the world. Orbia operates in the Polymer Solutions (Vestolit and Alphagary), Building and Infrastructure (Wavin), Precision Agriculture (Netafim), Data Communications (Dura-Line) and Fluorinated Solutions (Koura) sectors, with a collective focus on expanding access to health and wellness, reinventing the future of cities and homes, ensuring food and water security, connecting communities to data infrastructure and accelerating a sustainable, circular economy with basic and advanced materials and solutions.
- Industry Utilities
- Website https://www.orbia.com/
- LinkedIn https://www.linkedin.com/company/orbiaglobal/
Related People
Eitan DekelInvestor
United States -
Graton, California
An experienced Venture capitalist and corporate development executive,
Superior verbal and in-person communication skills, Strong analytical and technical background
Experience in strategy, product ,business development and financing.
Experience and track record in analyzing and identifying new technology trends and business models .
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)